COMMUNIQUÉS West-GlobeNewswire

HempAmericana Unveils New Web Presence Ahead of Expanded Commercial Operations
11/10/2018
NEW YORK, Oct. 11, 2018 (GLOBE NEWSWIRE) -- via OTC PR WIRE- HempAmericana, Inc. (OTC: HMPQ) (“HempAmericana” or the “Company”) is excited to announce the official launch of the Company’s new website ( www.hempamericana [...]
Insmed Presents New Data at IDWeek 2018 and CHEST Annual Meeting Enhancing the Understanding of MAC Lung Disease and Treatment with ARIKAYCE® (amikacin liposome inhalation suspension)
11/10/2018
BRIDGEWATER, N.J., Oct. 11, 2018 (GLOBE NEWSWIRE) -- Insmed Incorporated (Nasdaq:INSM), a global biopharmaceutical company focused on the unmet needs of patients with rare diseases, today announced that the Company [...]
Precision Therapeutics Continues to Build World Class Scientific Advisory Board with Appointment of Hector J. Gomez, MD, PhD
11/10/2018
MINNEAPOLIS, Oct. 11, 2018 (GLOBE NEWSWIRE) -- Precision Therapeutics Inc. (NASDAQ: AIPT) (“Precision” or “the Company”), a company focused on applying artificial intelligence to personalized medicine and drug discovery [...]
Scythian Biosciences Announces Major Milestone in U.S. Expansion
11/10/2018
Florida Department of Health Approves CannCure’s Purchase of 60% of the Equity of 3 Boys Farms Including the License to Operate as a Medical Marijuana Treatment Center in Florida 3 Boys Farms Gets Former Incredibles [...]
Allscripts to release third-quarter 2018 financial results November 1
11/10/2018
CHICAGO, Oct. 11, 2018 (GLOBE NEWSWIRE) -- Allscripts Healthcare Solutions, Inc . (Nasdaq:MDRX) will report its financial results for the three months ended September 30, 2018, after the close of stock market hours on [...]
Data from Celtaxsys’ Acebilustat Phase 2 Trial addressing Lung Inflammation in CF Patients to be presented at the North American Cystic Fibrosis Conference
11/10/2018
ATLANTA, Oct. 11, 2018 (GLOBE NEWSWIRE) -- Full results from the recently completed Phase 2 trial (EMPIRE-CF) of Celtaxsys’ acebilustat will be presented at the North American Cystic Fibrosis Conference to be held [...]
Abiomed Second Quarter Fiscal 2019 Earnings and Conference Call Notification
11/10/2018
DANVERS, Mass., Oct. 11, 2018 (GLOBE NEWSWIRE) -- Abiomed, Inc . (NASDAQ: ABMD) announced that on Thursday, November 1, 2018, the Company will release financial results for the second quarter of fiscal 2019. The Company [...]
iCAD Announces Exceptional Study Results Demonstrating Significant Advantages of Revolutionary Artificial Intelligence Technology for Digital Breast Tomosynthesis
11/10/2018
Results demonstrate unprecedented improvements in clinical performance and reading times, validating the substantial benefits of artificial intelligence when used with 3D mammography Company to showcase latest [...]
Spero Therapeutics Receives QIDP Designation from the U.S. FDA for the Development of SPR206
11/10/2018
CAMBRIDGE, Mass., Oct. 11, 2018 (GLOBE NEWSWIRE) -- Spero Therapeutics, Inc. (Nasdaq:SPRO), a multi-asset clinical-stage biopharmaceutical company focused on identifying, developing and commercializing novel treatments [...]
Sirona Biochem to Present at the 2018 Arctic Circle Assembly
11/10/2018
VANCOUVER, British Columbia, Oct. 11, 2018 (GLOBE NEWSWIRE) -- Sirona Biochem Corp . (TSX-V: SBM) (FSE: ZSB) (the “ Company ”) announced today that Chief Scientific Officer, Dr. Geraldine Deliencourt-Godefroy will [...]
Dermavant Sciences to Present Tapinarof Phase 2b Data on Patient-Reported Outcomes for Psoriasis and Atopic Dermatitis at the Fall Clinical Dermatology Conference
11/10/2018
BASEL, Switzerland, Oct. 11, 2018 (GLOBE NEWSWIRE) -- Dermavant Sciences, a dermatology-focused subsidiary of Roivant Sciences, today announced that two abstracts containing Phase 2b data on patient-reported outcomes in [...]
Biogen Advances Research to Improve Outcomes for Patients With Multiple Sclerosis
11/10/2018
Evidence supports potential of serum neurofilament light (sNfL) as clinically useful biomarker in MS; Biogen and Siemens Healthineers collaborate to develop sNfL blood test Real-world data add to the large body of [...]
ProMIS Neurosciences Identifies Novel Antibody Drug Candidates for Parkinson’s Disease
11/10/2018
Unique discovery platform generates new antibody candidates that block a root cause of Parkinson’s Disease TORONTO and CAMBRIDGE, Mass., Oct. 11, 2018 (GLOBE NEWSWIRE) -- ProMIS Neurosciences, Inc. (TSX: PMN) (OTCQB: [...]
Pain Therapeutics Announces Appointment of Chief Financial Officer
11/10/2018
AUSTIN, Texas, Oct. 11, 2018 (GLOBE NEWSWIRE) -- Pain Therapeutics, Inc. (Nasdaq: PTIE), a biopharmaceutical company, today announced that Mr. Eric Schoen will join its management team as Chief Financial Officer, [...]
Integrated Cannabis Company, Inc. Announces Fall 2018 Collaboration to Launch CBD Products in the Colorado Market
11/10/2018
THIS NEWS RELEASE IS NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, Oct. 11, 2018 (GLOBE NEWSWIRE) -- Integrated Cannabis Company, Inc. (CSE: ICAN, [...]
Acasti Pharma Announces Closing of $19.1 Million Underwritten Public Offering of Common Shares
11/10/2018
MONTRÉAL, Oct. 11, 2018 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (NASDAQ: ACST – TSX-V: ACST), a biopharmaceutical innovator focused on the research, development and commercialization of its prescription drug candidate [...]
Resonant Inc. Appoints Tech and Finance Executive Bob Tirva to its Board of Directors
11/10/2018
- Respected tech industry veteran brings more than 25 years of comprehensive financial expertise - GOLETA, Calif., Oct. 11, 2018 (GLOBE NEWSWIRE) -- Resonant Inc. (NASDAQ: RESN), a leader in transforming the way radio [...]
Data Presented at ECTRIMS 2018 Show Potential of MOSPD2 as a Novel Target for Treatment of CNS Inflammation, Such as Multiple Sclerosis
11/10/2018
TEL AVIV, Israel, Oct. 11, 2018 (GLOBE NEWSWIRE) -- VBL Therapeutics (Nasdaq: VBLT ), announced today that a study entitled “MOSPD2: A Novel Therapeutic Target for the Treatment of CNS Inflammation,” is being presented [...]
Oncolytics Biotech® Announces Publication of Positive Clinical Results for Pelareorep in Abstract for ESMO 2018 Congress
11/10/2018
- Pelareorep and FOLFIRI/B combination shows superior OS & PFS data in KRAS mutant colorectal cancer compared to historical data - CALGARY, Alberta and SAN DIEGO, Oct. 11, 2018 (GLOBE NEWSWIRE) -- Oncolytics Biotech [...]

Pages